Allianz Asset Management GmbH Buys 26,314 Shares of USANA Health Sciences, Inc. $USNA

Allianz Asset Management GmbH lifted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 126.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 47,203 shares of the company’s stock after purchasing an additional 26,314 shares during the quarter. Allianz Asset Management GmbH owned 0.26% of USANA Health Sciences worth $1,300,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in USNA. Tower Research Capital LLC TRC boosted its position in USANA Health Sciences by 382.5% in the second quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock valued at $73,000 after buying an additional 1,901 shares in the last quarter. CWM LLC increased its holdings in shares of USANA Health Sciences by 109.7% during the second quarter. CWM LLC now owns 2,762 shares of the company’s stock worth $84,000 after buying an additional 1,445 shares in the last quarter. Quantbot Technologies LP lifted its stake in shares of USANA Health Sciences by 19.5% in the 2nd quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock valued at $121,000 after acquiring an additional 646 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $202,000. Finally, Intech Investment Management LLC acquired a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $208,000. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have commented on USNA shares. Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, December 29th. Zacks Research downgraded USANA Health Sciences from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 7th. Two equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $36.00.

USANA Health Sciences Trading Down 0.0%

NYSE:USNA opened at $20.95 on Friday. USANA Health Sciences, Inc. has a 12 month low of $18.48 and a 12 month high of $38.32. The stock has a market capitalization of $382.97 million, a price-to-earnings ratio of 23.81, a PEG ratio of 0.90 and a beta of 0.67. The firm has a fifty day simple moving average of $20.68 and a two-hundred day simple moving average of $23.84.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.